The EEC network has over 200 active members from 30 countries and a further 400 experts represented in the wider ES community. Collaboration is key to increasing survival and quality of life for patients with this rare cancer. The EEC plays a vital role in this through providing networking opportunities, facilitating working groups, and leading on patient advocacy. The EEC is led by the EEC Executive Committee and is supported by Bone Cancer Research Trust and The Ewing’s Sarcoma Research Trust.
EEC Network, Next Meeting: 30 June - 02 July 2025. Book your place.
The next meeting of the EEC Network takes place on Monday 30 June and Tuesday 1 July 2025 together with the Bone Cancer Research Trust Advances in Ewing Sarcoma Research Meeting on Wednesday 2 July. The event will be held at Woburn House, London, and also available to join on Zoom. Places are limited, so secure your place today.
Contact the Coordination Team
- Professor Sandra Strauss, Senior Clinical Research Associate, Research Department of Oncology, UCL
- Dr Abigail Evans, Scientific Project Manager, UCL
eec@ucl.ac.uk
About the EEC
EEC activities are funded by the European Union (2014-2018) and include clinical trials, translational research, and the strengthening of both patient and public involvement and the ethical process.
Clinical Trials
The EURO Ewing Consortium supports clinical trials for Ewing sarcoma.
EEC Executive Committee
The Euro Ewing Consortium (EEC) Executive Committee was established in March 2020 and acts on behalf of its members to deliver on EEC aims and objectives. Meet our representatives.
EEC News and Events
Find out more about EEC news and events and related meetings from other organisations.
Local Therapy Ewing's Sarcoma
Radiotherapy and surgery for Ewing sarcoma.
Patients and the Public
The EURO EWING Consortium provides information on the activities of the EEC and Ewing's Sarcoma to patients and the public.
Research Outputs
See conference abstracts and Ewing sarcoma published papers in peer-reviewed journals.
Working Groups
The EEC brings together researchers and medical professionals from Europe and beyond, and fosters collaboration through working groups in areas of biology, new therapeutics and local therapy.
What does the EEC do?
Consultation and implementation
The EEC Executive Committee consults with the wider EEC network at meetings and through emails and surveys. These inform the priorities and programme of activities.
Collaboration
The EEC brings together Ewing's Sarcoma experts to collaborate on trials, biological research, patient advocacy, funding calls and to identify and overcome challenges.
Networking
The EEC connects organisations, trial groups and charities to ensure that communication and networking that is essential to the success of the Consortium is developed and maintained.
Improving outcomes
Clinical trials ensure that survival and quality of life is improved for Ewing Sarcoma patients. The EEC supports the clinical and biological research from the EU-funded programme which funded the Euro Ewing 2012 and rEECur trials as well as the more recent InterEwing1 and iEuroEwing trials for newly-diagnosed patients.
Patient advocacy
Patient advocates are fully involved at the strategic level with membership on the EEC Executive Committee, the EEC Local Therapy Working Groups, NEWTS Group and Trial Steering Committees.
EEC Newsletter
The tenth EEC newsletter is now available.
Watch our films
Patient advocacy has been a large part of the EEC project since 2013. Here are some of our patient advocates talking about how they have contributed to our research as well as an introduction to the EE2012 trial (closed) and the rEECur trial (open).
EEC Membership
Membership is open to those in Europe and outside of Europe who are active in ES research / treatment or patient advocacy. Before applying, you must have attended at least one EEC meeting.
To apply for EEC membership, please complete our online form and send your CV and two nominations from current EEC members to eec@ucl.ac.uk.
